YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
117 hedge funds and large institutions have $804M invested in Y-mAbs Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $1.11B → $804M (-$308M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $496K
Holders
117
Holding in Top 10
2
Calls
–
Puts
$496K
Top Buyers
| 1 | +$23.2M | |
| 2 | +$17.6M | |
| 3 | +$16.4M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$9.33M |
| 5 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
+$8.73M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$13.1M | |
| 3 | -$6.49M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.7M |
| 5 |
Axa
Paris,
France
|
-$4.68M |